Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 246 member C (FAM246C) is a human protein-coding gene annotated as encoding a protein known as Protein FAM246C[9][10][3]. It is listed as an official gene symbol and protein product in standard human gene databases[2][9][10]. FAM246C is not recognized as a therapeutic target such as a receptor, enzyme, transporter, or transcription factor; rather, its molecular function and relevance are largely uncharacterized, and it is frequently referred to as a "gene/pseudogene"[8][10]. Some research resources market knockout cell lines disrupting FAM246C for general exploration of gene function and its potential biological significance in cell signaling and apoptosis, including research contexts involving cancer, inflammation, or neurodegenerative disease models, but no direct disease role, validated biomarker, or drug interaction is established for this protein[1][10]. There is currently insufficient evidence to classify FAM246C as a druggable or established disease target, and documentation on its physiological or pathological relevance is minimal.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 246 member C (FAM246C).